Merck & Co., Inc. (MRK) SEC Filings & 10K Form

$129.82
+0.27 (+0.21%)
(As of 12:04 PM ET)

Recent Merck & Co., Inc. SEC Filings

DateFilerForm TypeView
05/06/2024
3:29 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:15 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:17 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
5:41 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:05 PM
Merck & Co., Inc. (Filer)
Form 10-K/A
04/11/2024
3:08 PM
Merck & Co., Inc. (Filer)
Form DEF 14A
04/11/2024
3:10 PM
Merck & Co., Inc. (Filer)
Form DEFA14A
04/11/2024
3:12 PM
Merck & Co., Inc. (Filer)
Form ARS
04/08/2024
12:56 PM
Larson Betty D (Reporting)
Merck & Co., Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/01/2024
4:16 PM
Inspire Investing, LLC (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
03/29/2024
3:12 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:14 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:16 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
3:18 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:57 PM
Bowyer Research, Inc. (Filed by)
Merck & Co., Inc. (Subject)
Form PX14A6G
03/11/2024
2:27 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:24 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
3:01 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:35 PM
Merck & Co., Inc. (Subject)
Oosthuizen Johannes Jacobus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/01/2024
5:39 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
2:29 PM
Evaxion Biotech A/S (Subject)
Merck & Co., Inc. (Filed by)
Form SC 13G
01/17/2024
4:52 PM
Harpoon Therapeutics, Inc. (Issuer)
Merck & Co., Inc. (Reporting)
MERCK SHARP & DOHME LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
3:27 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:18 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:27 PM
Merck & Co., Inc. (Issuer)
Smart Dalton (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2023
6:36 AM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
8:04 AM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
2:49 PM
Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
10:08 AM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
5:38 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
2:45 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
2:20 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
2:33 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
2:04 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:12 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2023
5:46 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
3:53 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:36 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:21 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
1:09 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
Gold Set to EXPLODE! (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!
06/27/2023
1:10 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/27/2023
1:11 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/31/2023
3:20 PM
LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
1:55 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
2:08 PM
Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
2:11 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
1:07 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
8:00 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:58 PM
Merck & Co., Inc. (Subject)
Form FWP
05/08/2023
7:17 AM
Merck & Co., Inc. (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:MRK) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners